Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aspen Aerogels (ASPN) Other Working Capital Changes (2016 - 2025)

Historic Other Working Capital Changes for Aspen Aerogels (ASPN) over the last 13 years, with Q3 2025 value amounting to $361000.0.

  • Aspen Aerogels' Other Working Capital Changes fell 9092.96% to $361000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$11.4 million, marking a year-over-year decrease of 16529.63%. This contributed to the annual value of $19.8 million for FY2024, which is 16800.43% up from last year.
  • Aspen Aerogels' Other Working Capital Changes amounted to $361000.0 in Q3 2025, which was down 9092.96% from -$1.9 million recorded in Q2 2025.
  • In the past 5 years, Aspen Aerogels' Other Working Capital Changes ranged from a high of $9.4 million in Q1 2024 and a low of -$12.9 million during Q1 2025
  • Over the past 5 years, Aspen Aerogels' median Other Working Capital Changes value was $1.4 million (recorded in 2021), while the average stood at $1.0 million.
  • As far as peak fluctuations go, Aspen Aerogels' Other Working Capital Changes soared by 143667.95% in 2024, and later plummeted by 23734.37% in 2025.
  • Over the past 5 years, Aspen Aerogels' Other Working Capital Changes (Quarter) stood at -$221000.0 in 2021, then surged by 765.16% to $1.5 million in 2022, then plummeted by 57.14% to $630000.0 in 2023, then skyrocketed by 383.97% to $3.0 million in 2024, then crashed by 88.16% to $361000.0 in 2025.
  • Its Other Working Capital Changes stands at $361000.0 for Q3 2025, versus -$1.9 million for Q2 2025 and -$12.9 million for Q1 2025.